Position in ABBV
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$64,128,692
+$8,582,834 QoQ
Shares Held
254,843
-0.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#328
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026UNITED CAPITAL FINANCIAL ADVISORS, LLC holds $392,709,829 across 14 Drug Manufacturers - General names. ABBV ranks #3 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
74,694 | $89,590,231 | |
| 2 | JNJ |
Johnson & Johnson
|
345,519 | $87,751,460 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
254,843 | $64,128,692 | |
| 4 | NVO |
Novo Nordisk A S
|
1,000,682 | $47,972,695 | |
| 5 | AMGN |
Amgen Inc
|
90,846 | $32,897,153 | |
| 6 | MRK |
Merck & Co., Inc.
|
142,059 | $18,254,581 | |
| 7 | NVS |
Novartis AG
|
89,770 | $14,068,754 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
108,152 | $13,663,923 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $64,128,692 | 254,843 | Shares | Defined | 2026-08-17 | |
| 2026-03-31 | $55,545,858 | 255,395 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,714,974 | 252,593 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $56,345,259 | 243,350 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $36,361,473 | 195,892 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $41,513,454 | 198,136 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $35,288,021 | 198,582 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $40,242,671 | 203,781 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $35,055,600 | 204,382 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $47,523,365 | 260,974 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $43,731,914 | 282,196 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $58,306,458 | 391,161 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $57,098,978 | 423,803 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $73,433,552 | 460,774 | Shares | Defined | 2023-08-15 | |
| 2022-12-31 | $77,695,623 | 480,760 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $67,640,900 | 503,993 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $86,226,476 | 562,983 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $82,217,977 | 507,174 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $68,706,563 | 507,434 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $55,278,628 | 512,456 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $58,818,242 | 522,179 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $55,092,096 | 509,075 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $56,319,004 | 525,609 | Shares | Defined | 2021-02-17 | |
| 2020-09-30 | $44,391,049 | 506,805 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $50,036,258 | 509,638 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $39,123,031 | 513,493 | Shares | Defined | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||